JMP Securities downgraded Piper Sandler from Mkt Outperform to Mkt Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/4/2026 | $350.00 | Market Perform → Outperform | Northland Capital |
| 1/26/2026 | $385.00 | Underperform | BofA Securities |
| 11/10/2025 | $386.00 | Neutral → Buy | Goldman |
| 7/10/2025 | $339.00 | Peer Perform → Outperform | Wolfe Research |
| 1/6/2025 | $317.00 | Buy → Neutral | Goldman |
| 1/10/2024 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 12/19/2023 | Outperform → Market Perform | Northland Capital | |
| 7/11/2022 | $132.00 | Outperform → Peer Perform | Wolfe Research |
4/A - PIPER SANDLER COMPANIES (0001230245) (Issuer)
Northland Capital upgraded Piper Sandler from Market Perform to Outperform and set a new price target of $350.00
BofA Securities initiated coverage of Piper Sandler with a rating of Underperform and set a new price target of $385.00
Goldman upgraded Piper Sandler from Neutral to Buy and set a new price target of $386.00
4 - PIPER SANDLER COMPANIES (0001230245) (Issuer)
4 - PIPER SANDLER COMPANIES (0001230245) (Issuer)
4 - PIPER SANDLER COMPANIES (0001230245) (Issuer)
8-K - PIPER SANDLER COMPANIES (0001230245) (Filer)
S-8 - PIPER SANDLER COMPANIES (0001230245) (Filer)
10-Q - PIPER SANDLER COMPANIES (0001230245) (Filer)
Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and MedtronicParticipation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture FundsProceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercializationBoard strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representin
Piper Sandler Companies (NYSE:PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper Sandler's financial sponsor group. "Rob and Tripp are each well-respected, creative bankers with proven track records. They have played a large role in the growth of the services & industrials group over the past several years. We loo
Industry veterans John Mori and Eric Friel to lead new group Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distressed assets, trade and insurance claims, reorganized equity and other securities issued by companies facing financial stress, including default or bankruptcy. Add
Piper Sandler Companies (NYSE:PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper Sandler's financial sponsor group. "Rob and Tripp are each well-respected, creative bankers with proven track records. They have played a large role in the growth of the services & industrials group over the past several years. We loo
Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. "We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising biopharma companies across the full spectrum of equity and M&A transactions, combined with his rare scientific and clinical perspective, makes him an exceptional addition to our group. Patrick's extensive relationships with management teams, boards o
Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. "Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue expanding our capabilities in this important and evolving space," said J.P. Peltier, global co-head of investment banking and capital markets. "I'm honored to step into this new role and excited to work alongside our talented te
Piper Sandler Companies (NYSE:PIPR) has released its most recent financial results. The complete earnings release can be found on the firm's website at pipersandler.com/earnings. Join the earnings conference call on Friday, May 1, 2026 at 7:30 a.m. CT. Dial-in: 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) Passcode: 5642050 Access the conference call audio webcast. A playback of the call will be available at pipersandler.com/earnings approximately three hours after the event. ABOUT PIPER SANDLER Piper Sandler Companies (NYSE:PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment bankin
Piper Sandler Companies (NYSE:PIPR), a leading investment bank, will release its first quarter 2026 financial results prior to the opening of the market on Friday, May 1, 2026. The earnings release will be available at the company's website at pipersandler.com/earnings. Chad Abraham, chairman and chief executive officer; Deb Schoneman, president; and Kate Clune, chief financial officer, will host a related conference call at 8:30 a.m. ET (7:30 a.m. CT) that same day to review the financial results. There will be a question and answer session following the review. Investors and analysts may participate in the live conference call by dialing 800 330-6710 (in the U.S.) or +1 312 471-1353 (
Piper Sandler Companies (NYSE:PIPR) has released its most recent financial results. The complete earnings release can be found on the firm's website at pipersandler.com/earnings. Join the earnings conference call on Friday, February 6, 2026, at 7:00 a.m. CT. Dial-in: 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) Passcode: 3387875. Access the conference call audio webcast. A playback of the call will be available at pipersandler.com/earnings approximately three hours after the event. For additional information on the stock split, please visit the Shareholder Information page on our website. ABOUT PIPER SANDLER Piper Sandler Companies (NYSE:PIPR) is a leadin
SC 13G/A - PIPER SANDLER COMPANIES (0001230245) (Subject)
SC 13G/A - PIPER SANDLER COMPANIES (0001230245) (Subject)
SC 13G/A - PIPER SANDLER COMPANIES (0001230245) (Subject)